Cequa (Cyclosporine) Patent Expiration, LOE Window & CMS Spending
Cequa (Cyclosporine) by Sun Pharmaceutical: FDA Orange Book LOE 2037-02-28, 16 AB generics, $96.5M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.
| Regulatory & Reimbursement Dimension | Verified Value |
|---|---|
| Consolidated Sponsor | Sun Pharmaceutical |
| FDA Application & Pathway | N210913 (NDA) |
| Exclusivity / Cliff Horizon | Long-Dated Protection (2036+) |
| Core Active-Ingredient LOE Date | Not listed / N/A |
| Last Listed Patent or Exclusivity Date | 2037-02-28 |
| Orange Book Patents (*PED Extensions) | 5 patents (0 *PED) |
| Active AB-Rated Generic Competitors | 16 |
| 2024 CMS Total Public Spend | $96.5M |
| 2024 Medicare Part D Spend | $76.6M |
| 2024 Medicaid Spend | $20.0M |
| Reported Wholesale Price Change (CA SB 17) | 1 WAC filings (max 16.5% 2-yr change) |